![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 47/50 | (2017.01) |
C07D 417/12 | (2013.01) | ||
A61K 9/14 | (2006.01) | ||
C07D 277/82 | (2013.01) | ||
A61P 25/16 | (2006.01) | ||
C07F 9/6541 | (2013.01) | ||
C07D 417/12 | (2006.01) | ||
A61K 31/428 | (2013.01) | ||
C07D 277/82 | (2006.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 25/02 | (2018.01) | ||
A61P 25/16 | (2018.01) | ||
A61P 43/00 | (2018.01) |
(11) | Patento numeris | 3377111 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16867091.7 |
Europos patento paraiškos padavimo data | 2016-11-17 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-09-26 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-29 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/062400 |
Data | 2016-11-17 |
(87) | Numeris | WO 2017/087594 |
Data | 2017-05-26 |
(30) | Numeris | Data | Šalis |
201562257533 P | 2015-11-19 | US |
(72) |
MARFAT, Anthony , US
|
(73) |
Biohaven Therapeutics Ltd. ,
215 Church Street, New Haven, CT 06510,
US
|
(54) | AMINE PRODRUGS OF PHARMACEUTICAL COMPOUNDS |
AMINE PRODRUGS OF PHARMACEUTICAL COMPOUNDS |